- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|compound 26h [PMID: 22148278] | SB-1317 | SB1317 | TG-02|
|TG02 is an orally active multi-kinase inhibitor, with a unique activity profile against CDKs, JAK2 and FLT3 [4-5]. Like pacritinib it is a small molecule macrocycle. TG02 was rationally designed to inhibit several key signaling pathways simultaneously with the aim of maximising anti-cancer efficacy. It is being investigated for its anti-leukemic potential [2-3].
The compound is administered as the citrate salt.
|CAS Registry No.||937270-47-8 (source: PubChem)|
|GtoPdb PubChem SID||315661180|
|Search Google for chemical match using the InChIKey||VXBAJLGYBMTJCY-NSCUHMNNSA-N|
|Search Google for chemicals with the same backbone||VXBAJLGYBMTJCY|
|Search UniChem for chemical match using the InChIKey||VXBAJLGYBMTJCY-NSCUHMNNSA-N|
|Search UniChem for chemicals with the same backbone||VXBAJLGYBMTJCY|